About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Biotechnology Developments
Portfolio
22.05.2024
Press releases
RBT at the Sirius.Biotech summit
12.02.2024
Press releases
RBT conducted preclinical studies of a new immunomodulating drug
22.12.2023
Press releases
RBT shares became available for trading on the Moscow Exchange over-the-counter market
26.09.2023
Press releases
RBT and Sirius University to develop antigens for influenza vaccines
13.07.2023
Press releases
Business angels have invested RUB 155 million in vaccine development
24.05.2023
Press releases
RBT’s pre-IPO orders are oversubscribed
13.04.2023
Press releases
RBT begins researching a new immunomodulatory drug
1
2
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
